what is glp 1 retatrutide GLP‑3 Really Is: Triple‑Receptor Drug Doctor's WARNING: The Dark Side

At the time of writing, retatrutide has not received marketing authorisation from the MHRA or the EMA, and therefore does not have an approved Summary of Product Characteristics (SmPC) or Patient Information Leaflet (PIL) in the UK

Wegovy has been indicated by the FDA to treat obesity, however, close monitoring is required

Starting a GLP-1 isnt a small decision

Check insurance coverage: Well verify what your insurance covers and explore patient assistance programs if needed

To explore a structured, evidence-based approach to metabolic health and weight management , connect directly with Mile High Fitness and Wellness and schedule your consultation today.